🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Douglas Miehm

Stock Analyst at RBC Capital

(4.25)
# 1,492
Out of 5,152 analysts
423
Total ratings
53%
Success rate
6.4%
Average return

Stocks Rated by Douglas Miehm

Eupraxia Pharmaceuticals Inc.
Nov 16, 2026
Maintained: Buy
Price Target: $19.77 → $19.86
Current: $10.86
Upside: +82.92%
Medical Facilities Corporation
Nov 13, 2026
Maintained: Hold
Price Target: $19.00
Current: $15.45
Upside: +22.98%
Apotex Health Corp.
Nov 13, 2026
Maintained: Buy
Price Target: $43.00 → $46.00
Current: $35.54
Upside: +29.43%
WELL Health Technologies Corp.
Nov 11, 2026
Maintained: Buy
Price Target: $7.00
Current: $3.59
Upside: +94.99%
MannKind
Nov 6, 2026
Reiterated: Hold
Price Target: $4.75 → $5
Current: $4.23
Upside: +18.20%
Knight Therapeutics Inc.
Nov 6, 2026
Reiterated: Buy
Price Target: $11.00 → $13.00
Current: $11.98
Upside: +8.51%
DRI Healthcare Trust
Nov 5, 2026
Reiterated: Buy
Price Target: $22.00
Current: $19.49
Upside: +12.88%
Ligand Pharmaceuticals
Nov 1, 2026
Reiterated: Buy
Price Target: $357
Current: $314.16
Upside: +13.64%
Aurinia Pharmaceuticals
Oct 30, 2026
Rated: Hold
Price Target: $16 → $18
Current: $16.30
Upside: +10.43%
Bausch + Lomb
Oct 29, 2026
Rated: Buy
Price Target: $21 → $23
Current: $21.37
Upside: +7.63%
Reiterated: Hold
Price Target: $12.70 → $14.11
Current: $11.78
Upside: +19.81%
Rated: Hold
Price Target: $25 → $37
Current: $36.49
Upside: +0.03%
Reiterated: Buy
Price Target: $7.84
Current: $16.26
Upside: -51.76%
Reiterated: Buy
Price Target: $2.51 → $3.5
Current: $0.3818
Upside: n/a
Reiterated: Hold
Price Target: $18 → $19
Current: $2.65
Upside: n/a
Reiterated: Buy
Price Target: €22.00
Current: €80.30
Upside: n/a
Rated: Hold
Price Target: $3 → $2.3
Current: $0.0001
Upside: n/a
Upgraded: Buy
Price Target: n/a
Current: $8.40
Upside: n/a